Changes in hematological profile of HIV infected pregnant women after receiving highly active antiretroviral therapy at Debreberhan referral hospital and Debreberhan health center, Debreberhan, Ethiopia
Journal Title: World Journal of Pharmaceutical Sciences - Year 2017, Vol 5, Issue 8
Abstract
Background: Hematological complications have been documented to be the second most common cause of morbidity and mortality in HIV positive persons. In addition, treatment of HIV/AIDS showed side effects on hematological parameters. This study assessed hematological profile of HIV infected pregnant women after initiation of highly active antiretroviral treatment including the new Tenofovir drug. Method: Retrospective cohort study was conducted to assess hematological profile of HIV infected pregnant women after initiation of HAART at Anti-Retroviral Therapy (ART) clinic of Debreberhan referral hospital and Debreberhan health center in Ethiopia from January to August 2016. Data was collected from 51 patient cards of pregnant women that are available at the two health facilities between September 2009 and August 2016.The data was entered into Excel spread sheet and it was transported into STATA software for analysis. All data were presented as mean ± Standard error of the mean. Comparisons were made using the Paired T-test. A p-value of <0.05 was considered as indicative of a statistically significant difference. Result: The result from the present study shows that the HAART initiation in pregnant women with HIV increases the CD4 cell count and decreases means corpuscular hemoglobin concentration whereas other hematological parameters assessed here (WBC, lymphocyte count, total mid cell count… PCT) are not significantly affected at ninety five percent confidence interval. From the total of fifty one patient cards with complete CD4 count, twenty nine patient cards were recorded with TDF/3TC/EFV ART regimen. The remaining twenty two patient cards were documented with AZT/3TC/NVP regimen. Comparing the effect of the two Regimens on CD4 count, TDF/3TC/EFV increases the CD4 count significantly in pregnant women with HIV (p<0.0001). The other regimen (AZT/3TC/NVP) also increases the CD4 count from initial value as it is indicated by positive paired mean difference but this increase in CD4 count after AZT/3TC/NVP initiation in pregnant women with HIV is not statistically significant at 95 percent confidence interval. Conclusion: HAART initiation in pregnant women with HIV increases the CD4 cell count and decreases means corpuscular hemoglobin concentration. TDF/3TC/EFV ART regimen increases the CD4 count in pregnant women with HIV.
Authors and Affiliations
Kassahun Dires
A study on association of fibrinogen and oxidative stress in prognosis of diabetic foot ulcer in tertiary government hospital
Diabetes mellitus is the most common metabolic disorder characterized by metabolic abnormalities and long term complications. Diabetic foot ulcer has poor prognosis and is a leading cause of amputation. Oxidative stress...
A review on solid dispersion and latest approaches used to improve solubility of poorly water soluble drugs
In the present day solubility of drugs in GIT fluids becomes necessary for the preparation of solid unit dosage forms of drugs. Otherwise if the drug has poor solubility then the drug does not show its effect properly in...
Complementary and alternative medicine use in children with haematological disorders
Objectives: To study pattern of complementary and alternative medicine(CAM) use in paediatric patients suffering from thalassemia and compare CAM use in patients of thalassemia and sickle cell disease(SCD). Methodology:...
The effects of Amlodipine plus Losartan combination versus Amlodipine alone on serum uric acid levels in hypertension at a tertiary care hospital of north India
The present study is designed to evaluate the effects of Amlodipine (AMLO) versus Amlodipine plus Losartan (LOS) on serum uric acid (SUA) levels and on other biochemical parameters in hypertension. 60 newly diagnosed hyp...
Evaluation of different diagnostic tests in respect to Diazo test against typhoid in Indian population
Typhoid fever is an important health issue in developing countries like India and its diagnosis is also difficult. Widal test is commonly used in developing countries for the diagnosis of typhoid. The main aim of this st...